Topics in multiple myeloma discussed at ASCO 2016
Expanding multiple myeloma advances beyond the US and Europe – an international initiative
What are the advantages of multiple myeloma maintenance therapy?
Can CAR T-cells be optimised to safely treat MM patients?
Mechanism of action of proteasome inhibitors